Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Public ClinicalTrials.gov record NCT00390234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Study identification
- NCT ID
- NCT00390234
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 63 participants
Conditions and interventions
Conditions
- Fallopian Tube Cancer
- Female Reproductive Cancer
- Ovarian Carcinosarcoma
- Ovarian Sarcoma
- Recurrent Ovarian Epithelial Cancer
- Recurrent Uterine Sarcoma
- Stage III Ovarian Epithelial Cancer
- Stage III Uterine Sarcoma
- Stage IV Ovarian Epithelial Cancer
- Stage IV Uterine Sarcoma
- Uterine Carcinosarcoma
- Uterine Leiomyosarcoma
Interventions
- ziv-aflibercept Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Aug 31, 2011
- Completion
- Jul 31, 2013
- Last update posted
- Dec 6, 2015
2006 – 2013
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | — |
| University of Southern California | Los Angeles | California | 90033-0804 | — |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637-1470 | — |
| Evanston CCOP-NorthShore University HealthSystem | Evanston | Illinois | 60201 | — |
| Peoria Gynecologic Oncology | Peoria | Illinois | 61603 | — |
| University of Michigan University Hospital | Ann Arbor | Michigan | 48109 | — |
| Fox Chase Cancer Center | Rockledge | Pennsylvania | 19046 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00390234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2015 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00390234 live on ClinicalTrials.gov.